Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

GermanyBack to Germany

Clinical trials in Baden-Baden

7 clinical trials in Baden-Baden, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Baden-Baden at a glance
7
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

7 trials in Baden-Baden

Open in trial search

Dry age-related macular degeneration

Recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:XELAFASLATIDE
  • Sponsor:ONL Therapeutics Inc.

Chronic lymphocytic leukaemia

Recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Acalabrutinib
  • Sponsor:University Of Cologne

Fallopian tube cancer+5

Recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Nord Ostdeutsche Gesellschaft Fuer Gynaekologische Onkologie e.V.

Triple negative breast cancer+4

Recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:WSG Women's Cancer Study Group GmbH

Breast cancer+2

Recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Trastuzumab Deruxtecan
  • Sponsor:WSG Women's Cancer Study Group GmbH

Breast cancer+4

Not recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Ribociclib
  • Sponsor:WSG Women's Cancer Study Group GmbH

Breast cancer+3

Not recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:WSG Women's Cancer Study Group GmbH

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Baden-Baden

What the registry says about research in the country

01 Baden-Baden
Eye Diseases and Ocular Physiology
Clinical research in Baden-Baden includes studies focused on eye diseases and ocular physiological phenomena, with attention on atrophic age-related macular degeneration. These trials are exploring ways to slow disease progression and better understand vision-related decline. Testing a new approach for geographic atrophy linked to AMD Evaluating treatment effectiveness in progressive retinal disease The goal is to improve care for patients facing gradual loss of vision through more effective targeted therapies.
Neoplasms in Breast Cancer Research
A major part of the clinical trial activity in the city centers on breast cancer, including HER2+, HR+/HER2-, and triple-negative early breast cancer. These studies are examining new treatment combinations to strengthen disease control and improve long-term outcomes. Assessing new therapy combinations for HER2+ early breast cancer Comparing treatment strategies in HR+/HER2- early breast cancer Studying options for triple-negative early breast cancer Research in this area is aimed at improving response rates and reducing the chance of recurrence after initial treatment.
Hemic and Lymphatic Diseases
Trials in hematologic malignancies are investigating new strategies for patients with high-risk chronic lymphocytic leukemia. The focus is on whether newer drug combinations can offer stronger disease control than current standard approaches. Evaluating combination treatment for high-risk CLL Studying outcomes in patients with adverse genetic risk factors These studies are designed to improve progression control and support more personalized treatment choices.
Ovarian and Gynecologic Cancer
Another active research area involves advanced ovarian cancer and related gynecologic cancers, including fallopian tube cancer, primary peritoneal cancer, and clear cell carcinoma of the ovary. The trials are examining treatment strategies for patients with no visible residual tumor after surgery. Studying maintenance approaches in HRD-positive high-grade ovarian cancer Evaluating recurrence prevention after primary tumor debulking These efforts aim to extend recurrence-free survival and refine post-surgical treatment planning.
Personalized Oncology in Early Breast Cancer
Several studies are exploring personalized cancer therapy for early-stage breast cancer, using treatment selection to match individual risk profiles. This includes approaches that combine targeted medicine, endocrine therapy, and other systemic treatments. Testing personalized treatment for intermediate- to high-risk HR+/HER2- breast cancer Comparing targeted therapy with standard adjuvant care Improving invasive disease-free survival in early cancer care In Baden-Baden, this line of research reflects a broader move toward more tailored and effective cancer treatment.
Back to GermanyAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.